I probably would have, but I was out of the office most of the day.
Today is the one-year anniversary of MNTA’s 58% decline on receiving a non-approvable letter from the FDA on the Lovenox ANDA. I acquired all of my MNTA shares on Nov 6-8, 2007 at an average cost of 5.46, and I have not sold any.